Blue Sky Asset Management’s Canopy Growth CGC Stock Holding History

Blue Sky Asset Management’s Portfolio CGC Stock Details CGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,926	Closed	-$278K	–	40
2020 Q1	$278K	Buy	+1,926	New	+$362K	0.11%	49

Other funds holding CGC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $128B AUM 35.83% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Blue Sky Asset Management's CGC Position: Q2 2020 in Review

Blue Sky Asset Management sold out of Canopy Growth (CGC) in Q2 2020, closing a stake of 1,926 shares — an estimated $278K sold.

Blue Sky Asset Management first reported a position in CGC in Q1 2020 and held it in 1 quarter. The position peaked at $278K in Q1 2020. 358 funds tracked by Wall St. Rank hold CGC as of Q2 2020.

Blue Sky Asset Management reported no remaining Canopy Growth position as of Q2 2020 after selling out during the quarter.
Blue Sky Asset Management sold 1,926 Canopy Growth shares in Q2 2020, an estimated $278K.
Blue Sky Asset Management first reported a position in Canopy Growth in Q1 2020 and held it in 1 quarter.
Blue Sky Asset Management's Canopy Growth position peaked at $278K in Q1 2020.
358 funds tracked by Wall St. Rank held Canopy Growth as of Q2 2020.

Based on Blue Sky Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.